GlassScriptPhysician profile
Steven K Gerhardt
NPI 1972609766
$9,038.48
in general payments reported to CMS, 2019-2025
69 companies · $1,998 in 2025
The $1,998 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,292 · 2020: $705 · 2021: $254 · 2022: $830 · 2023: $1,105 · 2024: $1,854 · 2025: $1,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,957.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,279.17 | 2021-2025 | |
| Ucb, INC. | $735.41 | 2019-2025 | Rystiggo, Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $594.30 | 2019-2025 | |
| Genentech USA, INC. | $329.31 | 2019-2023 | Enspryng, Ocrevus |
| Acadia Pharmaceuticals INC | $316.64 | 2019-2025 | Nuplazid, Daybue |
| Pfizer INC. | $313.65 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $284.57 | 2019-2024 | Soliris, Ultomiris |
| Eisai INC. | $274.60 | 2019-2025 | |
| Lilly USA, LLC | $261.62 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Biogen, INC. | $248.64 | 2019-2025 | Skyclarys, Skyclarys |
| Teva Pharmaceuticals USA, INC. | $209.20 | 2019-2025 | Austedo Xr, Austedo Xr |
| Merz Pharmaceuticals, LLC | $207.72 | 2022-2025 | Xeomin |
| Grifols USA, LLC | $190.26 | 2019-2025 | Gamunex-C |
| Vanda Pharmaceuticals INC. | $170.89 | 2025 | Ponvory |
| Csl Behring | $168.12 | 2019-2025 | Hizentra, Privigen |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gerhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.